Marchina van der Ende

Interpatient variability in the pharmacokinetics of the HIV non‐nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and <i>CYP2B6</i> polymorphism

David M. Burger, Ilse van der Heiden, Charles la Porte et al. · British Journal of Clinical Pharmacology · 2005 · 211 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial

Ingeborg E A Wijting, Casper Rokx, Charles A. Boucher et al. · The Lancet HIV · 2017 · 111 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1–Infected Women

Stein Schalkwijk, Angela Colbers, Déborah Konopnicki et al. · Clinical Infectious Diseases · 2017 · 72 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Clinical assessment of external pressure circulatory assistance in acute myocardial infarction

Ezra A. Amsterdam, John S. Banas, J. Michael Criley et al. · The American Journal of Cardiology · 1980 · 57 citations

Medicine, Cardiology, Surgery +12

Localization of beta 1 integrins and their extracellular ligands in human lymphoid tissues.

Timo K. van den Berg, Marchina van der Ende, Ed A. Döpp et al. · PubMed · 1993 · 55 citations

Life Sciences, Cell Biology, Molecular Biology +15